ID   ACON_HUMAN              Reviewed;         780 AA.
AC   Q99798; O75809; Q5JZ41; Q6FHX0; Q8TAQ6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   15-MAR-2017, entry version 176.
DE   RecName: Full=Aconitate hydratase, mitochondrial;
DE            Short=Aconitase;
DE            EC=4.2.1.3 {ECO:0000250|UniProtKB:P16276};
DE   AltName: Full=Citrate hydro-lyase;
DE   Flags: Precursor;
GN   Name=ACO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RA   Juang H.H., Chiou B.;
RT   "Cloning and structural characterization of human mitochondrial
RT   aconitase.";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9630632; DOI=10.1016/S0378-1119(98)00188-7;
RA   Mirel D.B., Marder K., Graziano J., Freyer G., Zhao Q., Mayeux R.,
RA   Wilhelmsen K.C.;
RT   "Characterization of the human mitochondrial aconitase gene (ACO2).";
RL   Gene 213:205-218(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 69-84; 234-245; 313-323; 379-395; 412-424;
RP   430-437; 507-520; 565-573; 608-628; 634-648 AND 657-671, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 69-83; 96-107; 371-396 AND 524-534.
RX   PubMed=1946331;
RA   Baldwin G.S., Seet K.L., Callaghan J., Toncich G., Toh B.H.,
RA   Moritz R.L., Rubira M.R., Simpson R.;
RT   "Purification and partial amino acid sequence of human aconitase.";
RL   Protein Seq. Data Anal. 4:63-67(1991).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-573 AND LYS-605, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   INVOLVEMENT IN OPA9, INVOLVEMENT IN ICRD, VARIANTS OPA9 VAL-74 AND
RP   ARG-661, AND VARIANTS ICRD ASP-259 AND ASN-736.
RX   PubMed=25351951; DOI=10.1136/jmedgenet-2014-102532;
RA   Metodiev M.D., Gerber S., Hubert L., Delahodde A., Chretien D.,
RA   Gerard X., Amati-Bonneau P., Giacomotto M.C., Boddaert N.,
RA   Kaminska A., Desguerre I., Amiel J., Rio M., Kaplan J., Munnich A.,
RA   Rotig A., Rozet J.M., Besmond C.;
RT   "Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause
RT   either isolated or syndromic optic neuropathy with encephalopathy and
RT   cerebellar atrophy.";
RL   J. Med. Genet. 51:834-838(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-697.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [17]
RP   VARIANT ICRD ARG-112, AND CHARACTERIZATION OF VARIANT ICRD ARG-112.
RX   PubMed=22405087; DOI=10.1016/j.ajhg.2012.01.009;
RA   Spiegel R., Pines O., Ta-Shma A., Burak E., Shaag A., Halvardson J.,
RA   Edvardson S., Mahajna M., Zenvirt S., Saada A., Shalev S., Feuk L.,
RA   Elpeleg O.;
RT   "Infantile cerebellar-retinal degeneration associated with a mutation
RT   in mitochondrial aconitase, ACO2.";
RL   Am. J. Hum. Genet. 90:518-523(2012).
CC   -!- FUNCTION: Catalyzes the isomerization of citrate to isocitrate via
CC       cis-aconitate. {ECO:0000250|UniProtKB:P16276}.
CC   -!- CATALYTIC ACTIVITY: Citrate = isocitrate.
CC       {ECO:0000250|UniProtKB:P16276}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000250|UniProtKB:P16276};
CC       Note=Binds 1 [4Fe-4S] cluster per subunit. Binding of a [3Fe-4S]
CC       cluster leads to an inactive enzyme.
CC       {ECO:0000250|UniProtKB:P16276};
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle;
CC       isocitrate from oxaloacetate: step 2/2.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P16276}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion
CC       {ECO:0000250|UniProtKB:P16276}.
CC   -!- DISEASE: Infantile cerebellar-retinal degeneration (ICRD)
CC       [MIM:614559]: A severe autosomal recessive neurodegenerative
CC       disorder characterized by onset between ages 2 and 6 months of
CC       truncal hypotonia, athetosis, seizures, and ophthalmologic
CC       abnormalities, particularly optic atrophy and retinal
CC       degeneration. Affected individuals show profound psychomotor
CC       retardation, with only some achieving rolling, sitting, or
CC       recognition of family. Brain MRI shows progressive cerebral and
CC       cerebellar degeneration. {ECO:0000269|PubMed:22405087,
CC       ECO:0000269|PubMed:25351951}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Optic atrophy 9 (OPA9) [MIM:616289]: A condition that
CC       features progressive visual loss in association with optic
CC       atrophy. Atrophy of the optic disk indicates a deficiency in the
CC       number of nerve fibers which arise in the retina and converge to
CC       form the optic disk, optic nerve, optic chiasm and optic tracts.
CC       {ECO:0000269|PubMed:25351951}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the aconitase/IPM isomerase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Aconitase entry;
CC       URL="https://en.wikipedia.org/wiki/Aconitase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U80040; AAB38416.1; -; mRNA.
DR   EMBL; U87939; AAC39921.1; -; Genomic_DNA.
DR   EMBL; U87926; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87927; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87928; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87929; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87930; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87931; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87932; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87933; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87934; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87935; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87936; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87937; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; U87938; AAC39921.1; JOINED; Genomic_DNA.
DR   EMBL; CR456365; CAG30251.1; -; mRNA.
DR   EMBL; CR536568; CAG38805.1; -; mRNA.
DR   EMBL; AL023553; CAI20278.1; -; Genomic_DNA.
DR   EMBL; AL008582; CAI20278.1; JOINED; Genomic_DNA.
DR   EMBL; AL008582; CAI17931.1; -; Genomic_DNA.
DR   EMBL; AL023553; CAI17931.1; JOINED; Genomic_DNA.
DR   EMBL; BC014092; AAH14092.1; -; mRNA.
DR   EMBL; BC026196; AAH26196.1; -; mRNA.
DR   CCDS; CCDS14017.1; -.
DR   PIR; S17526; S17526.
DR   PIR; T52543; T52543.
DR   RefSeq; NP_001089.1; NM_001098.2.
DR   UniGene; Hs.643610; -.
DR   ProteinModelPortal; Q99798; -.
DR   SMR; Q99798; -.
DR   BioGrid; 106566; 29.
DR   IntAct; Q99798; 3.
DR   MINT; MINT-2856402; -.
DR   STRING; 9606.ENSP00000216254; -.
DR   DrugBank; DB03964; 4-Hydroxy-Aconitate Ion.
DR   DrugBank; DB04351; Aconitate Ion.
DR   DrugBank; DB04072; Alpha-Methylisocitric Acid.
DR   DrugBank; DB01727; Isocitric Acid.
DR   DrugBank; DB04562; Tricarballylic Acid.
DR   iPTMnet; Q99798; -.
DR   PhosphoSitePlus; Q99798; -.
DR   SwissPalm; Q99798; -.
DR   BioMuta; ACO2; -.
DR   DMDM; 6686275; -.
DR   DOSAC-COBS-2DPAGE; Q99798; -.
DR   REPRODUCTION-2DPAGE; IPI00017855; -.
DR   REPRODUCTION-2DPAGE; Q99798; -.
DR   SWISS-2DPAGE; Q99798; -.
DR   UCD-2DPAGE; Q99798; -.
DR   EPD; Q99798; -.
DR   MaxQB; Q99798; -.
DR   PaxDb; Q99798; -.
DR   PeptideAtlas; Q99798; -.
DR   PRIDE; Q99798; -.
DR   DNASU; 50; -.
DR   Ensembl; ENST00000216254; ENSP00000216254; ENSG00000100412.
DR   GeneID; 50; -.
DR   KEGG; hsa:50; -.
DR   UCSC; uc003bac.3; human.
DR   CTD; 50; -.
DR   DisGeNET; 50; -.
DR   GeneCards; ACO2; -.
DR   HGNC; HGNC:118; ACO2.
DR   HPA; HPA001097; -.
DR   MalaCards; ACO2; -.
DR   MIM; 100850; gene.
DR   MIM; 614559; phenotype.
DR   MIM; 616289; phenotype.
DR   neXtProt; NX_Q99798; -.
DR   OpenTargets; ENSG00000100412; -.
DR   Orphanet; 313850; Infantile cerebellar-retinal degeneration.
DR   PharmGKB; PA24443; -.
DR   eggNOG; KOG0453; Eukaryota.
DR   eggNOG; COG1048; LUCA.
DR   GeneTree; ENSGT00860000133751; -.
DR   HOGENOM; HOG000224293; -.
DR   HOVERGEN; HBG000248; -.
DR   InParanoid; Q99798; -.
DR   KO; K01681; -.
DR   PhylomeDB; Q99798; -.
DR   TreeFam; TF300627; -.
DR   BioCyc; MetaCyc:HS02077-MONOMER; -.
DR   BRENDA; 4.2.1.3; 2681.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   UniPathway; UPA00223; UER00718.
DR   ChiTaRS; ACO2; human.
DR   GenomeRNAi; 50; -.
DR   PRO; PR:Q99798; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100412; -.
DR   CleanEx; HS_ACO2; -.
DR   ExpressionAtlas; Q99798; baseline and differential.
DR   Genevisible; Q99798; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0051538; F:3 iron, 4 sulfur cluster binding; IEA:Ensembl.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0003994; F:aconitate hydratase activity; EXP:Reactome.
DR   GO; GO:0005506; F:iron ion binding; IDA:MGI.
DR   GO; GO:0006101; P:citrate metabolic process; IDA:MGI.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0006102; P:isocitrate metabolic process; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0035900; P:response to isolation stress; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IDA:MGI.
DR   Gene3D; 3.20.19.10; -; 1.
DR   Gene3D; 3.30.499.10; -; 2.
DR   Gene3D; 3.40.1060.10; -; 1.
DR   InterPro; IPR015931; Acnase/IPM_dHydase_lsu_aba_1/3.
DR   InterPro; IPR001030; Acoase/IPM_deHydtase_lsu_aba.
DR   InterPro; IPR015928; Aconitase/3IPM_dehydase_swvl.
DR   InterPro; IPR015932; Aconitase/IPMdHydase_lsu_aba_2.
DR   InterPro; IPR018136; Aconitase_4Fe-4S_BS.
DR   InterPro; IPR006248; Aconitase_mito-like.
DR   InterPro; IPR000573; AconitaseA/IPMdHydase_ssu_swvl.
DR   Pfam; PF00330; Aconitase; 1.
DR   Pfam; PF00694; Aconitase_C; 1.
DR   PRINTS; PR00415; ACONITASE.
DR   SUPFAM; SSF52016; SSF52016; 1.
DR   SUPFAM; SSF53732; SSF53732; 1.
DR   TIGRFAMs; TIGR01340; aconitase_mito; 1.
DR   PROSITE; PS00450; ACONITASE_1; 1.
DR   PROSITE; PS01244; ACONITASE_2; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Acetylation; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Iron; Iron-sulfur; Lyase; Metal-binding;
KW   Mitochondrion; Neurodegeneration; Phosphoprotein; Polymorphism;
KW   Pyrrolidone carboxylic acid; Reference proteome; Transit peptide;
KW   Tricarboxylic acid cycle.
FT   TRANSIT       1     27       Mitochondrion. {ECO:0000250}.
FT   CHAIN        28    780       Aconitate hydratase, mitochondrial.
FT                                /FTId=PRO_0000000541.
FT   REGION      192    194       Substrate binding. {ECO:0000250}.
FT   REGION      670    671       Substrate binding. {ECO:0000250}.
FT   METAL       385    385       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       448    448       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL       451    451       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   BINDING      99     99       Substrate. {ECO:0000250}.
FT   BINDING     474    474       Substrate. {ECO:0000250}.
FT   BINDING     479    479       Substrate. {ECO:0000250}.
FT   BINDING     607    607       Substrate. {ECO:0000250}.
FT   MOD_RES      28     28       Pyrrolidone carboxylic acid.
FT                                {ECO:0000250|UniProtKB:P16276}.
FT   MOD_RES      31     31       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES      50     50       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES      50     50       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     138    138       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     138    138       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     144    144       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     144    144       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     233    233       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     233    233       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     411    411       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     549    549       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     559    559       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     573    573       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     573    573       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     577    577       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     591    591       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     605    605       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     605    605       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     628    628       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     670    670       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     689    689       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     723    723       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     723    723       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     730    730       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     730    730       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     736    736       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     739    739       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   MOD_RES     743    743       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KI0}.
FT   VARIANT      74     74       L -> V (in OPA9; dbSNP:rs141772938).
FT                                {ECO:0000269|PubMed:25351951}.
FT                                /FTId=VAR_073435.
FT   VARIANT     112    112       S -> R (in ICRD; functional expression
FT                                studies in yeast show that the mutant has
FT                                decreased function under growth
FT                                conditions requiring the TCA cycle and
FT                                the glyoxylate shunt; dbSNP:rs786200924).
FT                                {ECO:0000269|PubMed:22405087}.
FT                                /FTId=VAR_067543.
FT   VARIANT     259    259       G -> D (in ICRD; dbSNP:rs786204828).
FT                                {ECO:0000269|PubMed:25351951}.
FT                                /FTId=VAR_073436.
FT   VARIANT     661    661       G -> R (in OPA9; dbSNP:rs752034900).
FT                                {ECO:0000269|PubMed:25351951}.
FT                                /FTId=VAR_073437.
FT   VARIANT     697    697       T -> N (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036572.
FT   VARIANT     736    736       K -> N (in ICRD; dbSNP:rs786204829).
FT                                {ECO:0000269|PubMed:25351951}.
FT                                /FTId=VAR_073438.
FT   VARIANT     768    768       A -> S (in dbSNP:rs1804785).
FT                                /FTId=VAR_033297.
FT   CONFLICT     35     35       S -> T (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    136    136       G -> D (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    159    159       A -> D (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    167    167       K -> S (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    199    199       G -> D (in Ref. 4; CAG38805).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       G -> R (in Ref. 6; AAH26196).
FT                                {ECO:0000305}.
FT   CONFLICT    242    242       S -> T (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    270    270       P -> H (in Ref. 6; AAH26196).
FT                                {ECO:0000305}.
FT   CONFLICT    275    275       I -> M (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       L -> P (in Ref. 4; CAG38805).
FT                                {ECO:0000305}.
FT   CONFLICT    517    517       T -> K (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
FT   CONFLICT    553    553       G -> R (in Ref. 1; AAB38416).
FT                                {ECO:0000305}.
SQ   SEQUENCE   780 AA;  85425 MW;  58C9FFBDBDC63D5E CRC64;
     MAPYSLLVTR LQKALGVRQY HVASVLCQRA KVAMSHFEPN EYIHYDLLEK NINIVRKRLN
     RPLTLSEKIV YGHLDDPASQ EIERGKSYLR LRPDRVAMQD ATAQMAMLQF ISSGLSKVAV
     PSTIHCDHLI EAQVGGEKDL RRAKDINQEV YNFLATAGAK YGVGFWKPGS GIIHQIILEN
     YAYPGVLLIG TDSHTPNGGG LGGICIGVGG ADAVDVMAGI PWELKCPKVI GVKLTGSLSG
     WSSPKDVILK VAGILTVKGG TGAIVEYHGP GVDSISCTGM ATICNMGAEI GATTSVFPYN
     HRMKKYLSKT GREDIANLAD EFKDHLVPDP GCHYDQLIEI NLSELKPHIN GPFTPDLAHP
     VAEVGKVAEK EGWPLDIRVG LIGSCTNSSY EDMGRSAAVA KQALAHGLKC KSQFTITPGS
     EQIRATIERD GYAQILRDLG GIVLANACGP CIGQWDRKDI KKGEKNTIVT SYNRNFTGRN
     DANPETHAFV TSPEIVTALA IAGTLKFNPE TDYLTGTDGK KFRLEAPDAD ELPKGEFDPG
     QDTYQHPPKD SSGQHVDVSP TSQRLQLLEP FDKWDGKDLE DLQILIKVKG KCTTDHISAA
     GPWLKFRGHL DNISNNLLIG AINIENGKAN SVRNAVTQEF GPVPDTARYY KKHGIRWVVI
     GDENYGEGSS REHAALEPRH LGGRAIITKS FARIHETNLK KQGLLPLTFA DPADYNKIHP
     VDKLTIQGLK DFTPGKPLKC IIKHPNGTQE TILLNHTFNE TQIEWFRAGS ALNRMKELQQ
//
